A detailed history of Eaton Vance Management transactions in Embecta Corp. stock. As of the latest transaction made, Eaton Vance Management holds 45,574 shares of EMBC stock, worth $629,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,574
Previous 56,568 19.44%
Holding current value
$629,832
Previous $1.43 Million 8.44%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$24.0 - $33.42 $263,856 - $367,419
-10,994 Reduced 19.44%
45,574 $1.31 Million
Q2 2022

Aug 15, 2022

BUY
$24.78 - $33.36 $853,522 - $1.15 Million
34,444 Added 155.69%
56,568 $1.43 Million
Q1 2022

May 16, 2022

BUY
$33.33 - $47.0 $737,392 - $1.04 Million
22,124 New
22,124 $777,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $799M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.